New drug trial aims to reverse devastating muscle wasting in cancer
NCT ID NCT07168226
Summary
This study is testing an investigational drug called ASCA101 to see if it can help cancer patients with cachexia, a severe condition causing weight loss and muscle wasting. About 135 adults with certain solid tumors who have lost significant weight will receive either ASCA101, an existing treatment, or a placebo for 12 weeks. Researchers will measure changes in body weight, muscle mass, strength, and appetite to see if the new treatment is safe and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CACHEXIA; CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ajou University Hospital
Gyeonggi-do, Suwon-si, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Chung-Ang University Gwangmyeong Hospital
Gyeonggi-do, Gwangmyeong-si, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Korea University Anam Hospital
Seoul, Seongbuk-gu, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
National Cancer Center
Gyeonggi-do, Goyang-si, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Samsung Medical Center
Seoul, Gangnam-gu, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Seoul ST. Mary's hospital
Seoul, Seocho-gu, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.